Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celldex Therapeutics (CLDX) Revenue (2016 - 2025)

Celldex Therapeutics has reported Revenue over the past 16 years, most recently at $121000.0 for Q4 2025.

  • Quarterly results put Revenue at $121000.0 for Q4 2025, down 89.7% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (down 77.98% YoY), and the annual figure for FY2025 was $1.5 million, down 77.99%.
  • Revenue for Q4 2025 was $121000.0 at Celldex Therapeutics, down from $730000.0 in the prior quarter.
  • Over the last five years, Revenue for CLDX hit a ceiling of $4.1 million in Q4 2023 and a floor of $121000.0 in Q4 2025.
  • Median Revenue over the past 5 years was $695000.0 (2025), compared with a mean of $1.2 million.
  • Biggest five-year swings in Revenue: soared 1374.58% in 2021 and later tumbled 95.32% in 2022.
  • Celldex Therapeutics' Revenue stood at $334000.0 in 2021, then skyrocketed by 382.93% to $1.6 million in 2022, then skyrocketed by 156.11% to $4.1 million in 2023, then plummeted by 71.56% to $1.2 million in 2024, then tumbled by 89.7% to $121000.0 in 2025.
  • The last three reported values for Revenue were $121000.0 (Q4 2025), $730000.0 (Q2 2025), and $695000.0 (Q1 2025) per Business Quant data.